AtriCure (ATRC) CLO Karl S. Dahlquist Sells Shares

What Happened

Karl S. Dahlquist, Chief Legal Officer of AtriCure, sold 9,370 shares of ATRC in open-market transactions on August 24, 2026. The trades generated approximately $458,099 in proceeds at a weighted average price of $48.89 per share. This was a sale (not a purchase or option exercise) and is typically considered routine insider selling rather than a direct signal of company prospects.

Key Details

• Transaction date: 2026-08-24 (reported on Form 4 filed 2026-08-26).
• Action/type: Sale (code S), open-market or private sale executed in multiple trades.
• Price: Trades ranged $48.88–$48.89; weighted average reported $48.89/share.
• Shares sold: 9,370; proceeds ≈ $458,099.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: The filer says the sale was executed in multiple trades and will provide detailed per-trade quantities/prices on request.
• Timeliness: Filed two days after the trade; appears timely for a Form 4.

Context

Insider sales can be for many personal or routine reasons (diversification, tax planning, liquidity) and do not by themselves prove management views. Purchases are generally more informative about insider sentiment than routine sales. If you follow insider activity, watch for patterns (multiple insiders buying or selling) or material changes combined with other company news.